These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prognostic value of bronchial provocation and FENO measurement for asthma diagnosis--results of a delayed type of diagnostic study. Schneider A, Faderl B, Schwarzbach J, Welker L, Karsch-Völk M, Jörres RA. Respir Med; 2014 Jan; 108(1):34-40. PubMed ID: 24315470 [Abstract] [Full Text] [Related]
3. Diagnosing asthma in general practice with portable exhaled nitric oxide measurement--results of a prospective diagnostic study: FENO < or = 16 ppb better than FENO < or =12 ppb to rule out mild and moderate to severe asthma [added]. Schneider A, Tilemann L, Schermer T, Gindner L, Laux G, Szecsenyi J, Meyer FJ. Respir Res; 2009 Mar 03; 10(1):15. PubMed ID: 19254389 [Abstract] [Full Text] [Related]
4. Influence of the practice setting on diagnostic prediction rules using FENO measurement in combination with clinical signs and symptoms of asthma. Schneider A, Wagenpfeil G, Jörres RA, Wagenpfeil S. BMJ Open; 2015 Nov 24; 5(11):e009676. PubMed ID: 26603255 [Abstract] [Full Text] [Related]
6. Diagnostic utility of inflammatory biomarkers in asthma: exhaled nitric oxide and induced sputum eosinophil count. Fortuna AM, Feixas T, González M, Casan P. Respir Med; 2007 Nov 24; 101(11):2416-21. PubMed ID: 17714927 [Abstract] [Full Text] [Related]
7. [Values of fractional exhaled nitric oxide in the diagnosis of chronic cough]. Zhang YM, Lin JT, Su N, Chen X, Liu GL, Yu HX, Nong Y, Zhang XY, Yang M, He J, Li YM. Zhonghua Yi Xue Za Zhi; 2011 May 17; 91(18):1254-8. PubMed ID: 21756797 [Abstract] [Full Text] [Related]
9. Importance of fractional exhaled nitric oxide in the differentiation of asthma-COPD overlap syndrome, asthma, and COPD. Chen FJ, Huang XY, Liu YL, Lin GP, Xie CM. Int J Chron Obstruct Pulmon Dis; 2016 May 17; 11():2385-2390. PubMed ID: 27713629 [Abstract] [Full Text] [Related]
11. Validation study of asthma screening criteria based on subjective symptoms and fractional exhaled nitric oxide. Fukuhara A, Saito J, Sato S, Sato Y, Nikaido T, Saito K, Fukuhara-Nakagawa N, Inokoshi Y, Ishii T, Tanino Y, Ishida T, Munakata M. Ann Allergy Asthma Immunol; 2011 Dec 17; 107(6):480-6. PubMed ID: 22123376 [Abstract] [Full Text] [Related]
12. Correlation of eosinophil counts in induced sputum and fractional concentration of exhaled nitric oxide and lung functions in patients with mild to moderate asthma. Wang W, Huang KW, Wu BM, Wang YJ, Wang C. Chin Med J (Engl); 2012 Sep 17; 125(17):3157-60. PubMed ID: 22932198 [Abstract] [Full Text] [Related]
15. [Cutoff point of the fraction of exhaled nitric oxide (FeNO) with the off-line method for diagnosing asthma and the effect of smoking on FeNO]. Oshikata C, Tsuburai T, Tsurikisawa N, Ono E, Higashi A, Fukutomi Y, Tanimoto H, Sekiya K, Otomo M, Maeda Y, Taniguchi M, Ikehara K, Akiyama K. Nihon Kokyuki Gakkai Zasshi; 2008 May 17; 46(5):356-62. PubMed ID: 18517010 [Abstract] [Full Text] [Related]
16. The value of exhaled nitric oxide to identify asthma in smoking patients with asthma-like symptoms. Malinovschi A, Backer V, Harving H, Porsbjerg C. Respir Med; 2012 Jun 17; 106(6):794-801. PubMed ID: 22405608 [Abstract] [Full Text] [Related]
17. Is FENO50 useful diagnostic tool in suspected asthma? Schleich FN, Asandei R, Manise M, Sele J, Seidel L, Louis R. Int J Clin Pract; 2012 Feb 17; 66(2):158-65. PubMed ID: 22257040 [Abstract] [Full Text] [Related]
19. The value of sputum 8-isoprostane in detecting oxidative stress in mild asthma. Louhelainen N, Rytilä P, Obase Y, Mäkelä M, Haahtela T, Kinnula VL, Pelkonen A. J Asthma; 2008 Mar 17; 45(2):149-54. PubMed ID: 18350407 [Abstract] [Full Text] [Related]
20. Validity of Fractional Exhaled Nitric Oxide in Diagnosis of Corticosteroid-Responsive Cough. Yi F, Chen R, Luo W, Xu D, Han L, Liu B, Jiang S, Chen Q, Lai K. Chest; 2016 Apr 17; 149(4):1042-51. PubMed ID: 26836931 [Abstract] [Full Text] [Related] Page: [Next] [New Search]